Rosuvastatin: Beyond the cholesterol-lowering effect
Rosuvastatin is a fully synthetic statin wich acts by interfering with the endogenous synthesis
of cholesterol through competitively inhibiting the 3-hydroxy-3-methylglutaryl coenzyme A …
of cholesterol through competitively inhibiting the 3-hydroxy-3-methylglutaryl coenzyme A …
Rosuvastatin: Beyond the cholesterol-lowering effect.
F Cortese, M Gesualdo, A Cortese… - PHARMACOLOGICAL …, 2016 - ricerca.uniba.it
Rosuvastatin is a fully synthetic statin wich acts by interfering with the endogenous synthesis
of cholesterol through competitively inhibiting the 3-hydroxy-3-methylglutaryl coenzyme A …
of cholesterol through competitively inhibiting the 3-hydroxy-3-methylglutaryl coenzyme A …
Rosuvastatin: Beyond the cholesterol-lowering effect
F Cortese, M Gesualdo, A Cortese… - Pharmacological …, 2016 - pubmed.ncbi.nlm.nih.gov
Rosuvastatin is a fully synthetic statin wich acts by interfering with the endogenous synthesis
of cholesterol through competitively inhibiting the 3-hydroxy-3-methylglutaryl coenzyme A …
of cholesterol through competitively inhibiting the 3-hydroxy-3-methylglutaryl coenzyme A …
Rosuvastatin: Beyond the cholesterol-lowering effect.
F Cortese, M Gesualdo, A Cortese… - Pharmacological …, 2016 - europepmc.org
Rosuvastatin is a fully synthetic statin wich acts by interfering with the endogenous synthesis
of cholesterol through competitively inhibiting the 3-hydroxy-3-methylglutaryl coenzyme A …
of cholesterol through competitively inhibiting the 3-hydroxy-3-methylglutaryl coenzyme A …
[引用][C] Rosuvastatin: Beyond the cholesterol-lowering effect
F Cortese, M Gesualdo, A Cortese… - Pharmacological …, 2016 - cir.nii.ac.jp
Rosuvastatin: Beyond the cholesterol-lowering effect
F Cortese, M Gesualdo, A Cortese, S Carbonara… - Pharmacological …, 2016 - infona.pl
Rosuvastatin is a fully synthetic statin wich acts by interfering with the endogenous synthesis
of cholesterol through competitively inhibiting the 3-hydroxy-3-methylglutaryl coenzyme A …
of cholesterol through competitively inhibiting the 3-hydroxy-3-methylglutaryl coenzyme A …